Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2025-03-04 Sale | 2025-03-06 6:55 pm | LIGAND PHARMACEUTICALS INC | LGND | Espinoza Octavio Chief Financial Officer | 5,000 | $115.03 | $575,149 | 59,080 (Direct) | View |
| 2024-12-23 Sale | 2024-12-26 8:32 pm | LIGAND PHARMACEUTICALS INC | LGND | Espinoza Octavio Chief Financial Officer | 2,104 | $116.37 | $244,850 | 20,647 (Direct) | View |
| 2024-11-27 Sale | 2024-12-02 8:05 pm | LIGAND PHARMACEUTICALS INC | LGND | LAMATTINA JOHN L Director | 2,406 | $123.65 | $297,502 | 29,515 (Direct) | View |
| 2024-09-23 Sale | 2024-09-25 8:54 pm | LIGAND PHARMACEUTICALS INC | LGND | Reardon Andrew CLO & Secretary | 2,000 | $99.6 | $199,201 | 93,478 (Direct) | View |
| 2024-09-20 Sale | 2024-09-24 7:41 pm | LIGAND PHARMACEUTICALS INC | LGND | Espinoza Octavio Chief Financial Officer | 1,275 | $103.94 | $132,518 | 24,610 (Direct) | View |
| 2024-09-20 Sale | 2024-09-24 7:41 pm | LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E President & COO | 16,047 | $102.35 | $1,642,359 | 93,608 (Direct) | View |
| 2024-08-28 Sale | 2024-08-30 8:56 pm | LIGAND PHARMACEUTICALS INC | LGND | Reardon Andrew CLO & Secretary | 1,500 | $106.39 | $159,591 | 83,978 (Direct) | View |
| 2024-08-22 Sale | 2024-08-26 8:15 pm | LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E President & COO | 18,858 | $105.34 | $1,986,420 | 49,510 (Direct) | View |
| 2024-08-09 Sale | 2024-08-13 5:21 pm | LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E President & COO | 18,245 | $98.5 | $1,797,133 | 68,368 (Direct) | View |
| 2024-08-08 Purchase | 2024-08-09 5:52 pm | LIGAND PHARMACEUTICALS INC | LGND | Davis Todd C Chief Executive Officer | 2,500 | $97.39 | $243,481 | 123,010 (Direct) | View |
| 2024-05-09 Sale | 2024-05-17 8:00 pm | LIGAND PHARMACEUTICALS INC | LGND | Gray Nancy Ryan Director | 934 | $83.2 | $77,713 | 5,633 (Direct) | View |
| 2024-05-15 Sale | 2024-05-17 7:59 pm | LIGAND PHARMACEUTICALS INC | LGND | Espinoza Octavio Chief Financial Officer | 13,293 | $86.26 | $1,146,704 | 65,530 (Direct) | View |
| 2024-05-13 Sale | 2024-05-15 7:34 pm | LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E President & Chief Operating | 17,598 | $84.99 | $1,495,740 | 86,263 (Direct) | View |
| 2024-05-09 Sale | 2024-05-13 5:32 pm | LIGAND PHARMACEUTICALS INC | LGND | Reardon Andrew Chief Legal Officer & | 10,000 | $83.04 | $830,449 | 85,149 (Direct) | View |
| 2024-03-05 Sale | 2024-03-07 1:27 pm | LIGAND PHARMACEUTICALS INC | LGND | Sabba Stephen L Director | 1,893 | $74.3 | $140,650 | 29,345 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-04-01 Exercise | 2025-04-16 09:34 am | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Sabba Stephen L Director | 2,406 | $52.3 | 32,584 (Direct) | View |
| 2025-04-01 Exercise | 2025-04-16 09:34 am | N/A 2025-04-24 | LIGAND PHARMACEUTICALS INC | LGND | Sabba Stephen L Director | 2,406 | $0 | 32,584 (Direct) | View |
| 2025-03-04 Option Award | 2025-03-06 6:55 pm | N/A 2035-03-04 | LIGAND PHARMACEUTICALS INC | LGND | Reardon Andrew CLO & Secretary | 34,458 | $0 | 62,826 (Direct) | View |
| 2025-03-04 Option Award | 2025-03-06 6:55 pm | N/A 2035-03-04 | LIGAND PHARMACEUTICALS INC | LGND | Espinoza Octavio Chief Financial Officer | 40,201 | $0 | 59,080 (Direct) | View |
| 2025-03-04 Option Award | 2025-03-06 6:54 pm | N/A 2035-03-04 | LIGAND PHARMACEUTICALS INC | LGND | Davis Todd C Chief Executive Officer | 114,858 | $0 | 245,200 (Direct) | View |
| 2025-02-14 Tax Withholding | 2025-02-19 8:44 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Davis Todd C Chief Executive Officer | 13,452 | $120 | 130,342 (Direct) | View |
| 2025-02-14 Option Award | 2025-02-19 8:44 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Davis Todd C Chief Executive Officer | 20,784 | $0 | 130,342 (Direct) | View |
| 2025-02-14 Tax Withholding | 2025-02-19 8:38 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Espinoza Octavio Chief Financial Officer | 9,587 | $120 | 23,879 (Direct) | View |
| 2025-02-14 Option Award | 2025-02-19 8:38 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Espinoza Octavio Chief Financial Officer | 12,819 | $0 | 23,879 (Direct) | View |
| 2025-02-14 Tax Withholding | 2025-02-19 8:37 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Reardon Andrew CLO & Secretary | 6,523 | $120 | 28,368 (Direct) | View |
| 2025-02-14 Option Award | 2025-02-19 8:37 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Reardon Andrew CLO & Secretary | 12,357 | $0 | 28,368 (Direct) | View |
| 2024-12-05 Tax Withholding | 2024-12-06 7:55 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Espinoza Octavio Chief Financial Officer | 1,859 | $123.51 | 22,751 (Direct) | View |
| 2024-11-27 Exercise | 2024-12-02 8:05 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | LAMATTINA JOHN L Director | 2,406 | $52.3 | 29,515 (Direct) | View |
| 2024-11-27 Exercise | 2024-12-02 8:05 pm | N/A 2025-04-24 | LIGAND PHARMACEUTICALS INC | LGND | LAMATTINA JOHN L Director | 2,406 | $0 | 29,515 (Direct) | View |
| 2024-09-23 Exercise | 2024-09-25 8:54 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Reardon Andrew CLO & Secretary | 2,000 | $52.27 | 93,478 (Direct) | View |
| 2024-09-23 Exercise | 2024-09-25 8:54 pm | N/A 2032-08-01 | LIGAND PHARMACEUTICALS INC | LGND | Reardon Andrew CLO & Secretary | 2,000 | $0 | 93,478 (Direct) | View |
| 2024-09-23 Exercise | 2024-09-24 7:41 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E President & COO | 9,377 | $52.84 | 93,608 (Direct) | View |
| 2024-09-20 Exercise | 2024-09-24 7:41 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E President & COO | 5,377 | $49.99 | 93,608 (Direct) | View |
| 2024-09-20 Exercise | 2024-09-24 7:41 pm | N/A 2026-02-11 | LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E President & COO | 14,754 | $0 | 93,608 (Direct) | View |
| 2024-09-17 Exercise | 2024-09-19 5:50 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Espinoza Octavio Chief Financial Officer | 69 | $57.22 | 33,591 (Direct) | View |
| 2024-09-17 Exercise | 2024-09-19 5:50 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Espinoza Octavio Chief Financial Officer | 1,417 | $80.72 | 33,591 (Direct) | View |
| 2024-09-17 Exercise | 2024-09-19 5:50 pm | N/A 2030-10-01 | LIGAND PHARMACEUTICALS INC | LGND | Espinoza Octavio Chief Financial Officer | 1,486 | $0 | 33,591 (Direct) | View |
| 2024-09-16 Exercise | 2024-09-18 7:55 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E President & COO | 914 | $55.75 | 114,348 (Direct) | View |
| 2024-09-16 Exercise | 2024-09-18 7:55 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E President & COO | 3,340 | $60.94 | 114,348 (Direct) | View |
| 2024-09-16 Exercise | 2024-09-18 7:55 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E President & COO | 671 | $49.99 | 114,348 (Direct) | View |
| 2024-09-16 Tax Withholding | 2024-09-18 7:55 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E President & COO | 3,214 | $105 | 114,348 (Direct) | View |
| 2024-09-16 Exercise | 2024-09-18 7:55 pm | N/A 2026-02-11 | LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E President & COO | 5,774 | $0 | 114,348 (Direct) | View |
| 2024-09-16 Exercise | 2024-09-18 7:55 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E President & COO | 849 | $58.49 | 114,348 (Direct) | View |
| 2024-08-28 Exercise | 2024-08-30 9:00 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Espinoza Octavio Chief Financial Officer | 546 | $70.04 | 31,708 (Direct) | View |
| 2024-08-28 Exercise | 2024-08-30 9:00 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Espinoza Octavio Chief Financial Officer | 207 | $57.22 | 31,708 (Direct) | View |
| 2024-08-28 Exercise | 2024-08-30 9:00 pm | N/A 2030-10-01 | LIGAND PHARMACEUTICALS INC | LGND | Espinoza Octavio Chief Financial Officer | 753 | $0 | 31,708 (Direct) | View |
| 2024-08-28 Exercise | 2024-08-30 8:56 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Reardon Andrew CLO & Secretary | 1,500 | $52.27 | 83,978 (Direct) | View |
| 2024-08-28 Exercise | 2024-08-30 8:56 pm | N/A 2032-08-01 | LIGAND PHARMACEUTICALS INC | LGND | Reardon Andrew CLO & Secretary | 1,500 | $0 | 83,978 (Direct) | View |
| 2024-06-28 Other | 2024-07-02 7:45 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Reardon Andrew Chief Legal Officer & | 329 | $60.71 | 22,863 (Direct) | View |
| 2024-06-28 Other | 2024-07-02 7:45 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E President & Chief Operating | 350 | $60.71 | 86,963 (Direct) | View |
| 2024-06-28 Other | 2024-07-02 7:45 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Espinoza Octavio Chief Financial Officer | 267 | $60.71 | 23,913 (Direct) | View |
| 2024-06-28 Other | 2024-07-02 7:44 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Davis Todd C Chief Executive Officer | 350 | $60.71 | 120,860 (Direct) | View |
| 2024-06-14 Option Award | 2024-06-25 7:45 pm | N/A 2034-06-14 | LIGAND PHARMACEUTICALS INC | LGND | Sabba Stephen L Director | 6,696 | $0 | 35,622 (Direct) | View |
| 2024-06-14 Option Award | 2024-06-18 9:27 pm | N/A 2034-06-14 | LIGAND PHARMACEUTICALS INC | LGND | Zimmermann Martine Director | 6,696 | $0 | 8,981 (Direct) | View |
| 2024-06-14 Option Award | 2024-06-18 9:27 pm | N/A 2034-06-14 | LIGAND PHARMACEUTICALS INC | LGND | LAMATTINA JOHN L Director | 6,696 | $0 | 34,959 (Direct) | View |
| 2024-06-14 Option Award | 2024-06-18 9:26 pm | N/A 2034-06-14 | LIGAND PHARMACEUTICALS INC | LGND | KOZARICH JOHN W Director | 6,696 | $0 | 49,219 (Direct) | View |
| 2024-06-14 Option Award | 2024-06-18 9:26 pm | N/A 2034-06-14 | LIGAND PHARMACEUTICALS INC | LGND | Haas Jason Director | 6,696 | $0 | 10,841 (Direct) | View |
| 2024-06-14 Option Award | 2024-06-18 9:26 pm | N/A 2034-06-14 | LIGAND PHARMACEUTICALS INC | LGND | Gray Nancy Ryan Director | 6,696 | $0 | 12,329 (Direct) | View |
| 2024-06-14 Option Award | 2024-06-18 9:25 pm | N/A 2034-06-14 | LIGAND PHARMACEUTICALS INC | LGND | Aryeh Jason Director | 6,696 | $0 | 140,143 (Direct) | View |
| 2024-05-17 Exercise | 2024-05-17 7:59 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Espinoza Octavio Chief Financial Officer | 206 | $57.22 | 65,530 (Direct) | View |
| 2024-05-17 Exercise | 2024-05-17 7:59 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Espinoza Octavio Chief Financial Officer | 1,544 | $63.62 | 65,530 (Direct) | View |
| 2024-05-17 Exercise | 2024-05-17 7:59 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Espinoza Octavio Chief Financial Officer | 5,022 | $52.84 | 65,530 (Direct) | View |
| 2024-05-17 Exercise | 2024-05-17 7:59 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Espinoza Octavio Chief Financial Officer | 145 | $68.74 | 65,530 (Direct) | View |
| 2024-05-17 Exercise | 2024-05-17 7:59 pm | N/A 2030-10-01 | LIGAND PHARMACEUTICALS INC | LGND | Espinoza Octavio Chief Financial Officer | 6,917 | $0 | 65,530 (Direct) | View |
| 2024-05-09 Exercise | 2024-05-13 5:32 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Reardon Andrew Chief Legal Officer & | 10,000 | $52.27 | 85,149 (Direct) | View |
| 2024-05-09 Exercise | 2024-05-13 5:32 pm | N/A 2032-08-01 | LIGAND PHARMACEUTICALS INC | LGND | Reardon Andrew Chief Legal Officer & | 10,000 | $0 | 85,149 (Direct) | View |
| 2024-04-30 Exercise | 2024-05-02 6:07 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Aryeh Jason Director | 2,406 | $52.3 | 133,447 (Direct) | View |
| 2024-04-30 Exercise | 2024-05-02 6:07 pm | N/A 2025-04-24 | LIGAND PHARMACEUTICALS INC | LGND | Aryeh Jason Director | 2,406 | $0 | 133,447 (Direct) | View |
| 2024-04-24 Exercise | 2024-04-26 6:35 pm | N/A 2024-06-04 | LIGAND PHARMACEUTICALS INC | LGND | KOZARICH JOHN W Director | 2,893 | $0 | 42,523 (Direct) | View |
| 2024-04-24 Exercise | 2024-04-26 6:35 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | KOZARICH JOHN W Director | 2,893 | $39.35 | 42,523 (Direct) | View |
| 2024-03-25 Exercise | 2024-03-27 5:47 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Davis Todd C Chief Executive Officer | 3,556 | $66.19 | 120,160 (Direct) | View |
| 2024-03-25 Exercise | 2024-03-27 5:47 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Davis Todd C Chief Executive Officer | 2,156 | $68.51 | 120,160 (Direct) | View |
| 2024-03-25 Exercise | 2024-03-27 5:47 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Davis Todd C Chief Executive Officer | 7,448 | $46.2 | 120,160 (Direct) | View |
| 2024-03-25 Exercise | 2024-03-27 5:47 pm | N/A 2032-06-10 | LIGAND PHARMACEUTICALS INC | LGND | Davis Todd C Chief Executive Officer | 16,015 | $0 | 120,160 (Direct) | View |
| 2024-03-25 Exercise | 2024-03-27 5:47 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Davis Todd C Chief Executive Officer | 2,855 | $67.24 | 120,160 (Direct) | View |
| 2024-03-05 Exercise | 2024-03-07 1:27 pm | N/A 2024-06-04 | LIGAND PHARMACEUTICALS INC | LGND | Sabba Stephen L Director | 2,893 | $0 | 29,345 (Direct) | View |
| 2024-03-05 Exercise | 2024-03-06 5:28 pm | N/A 2024-06-04 | LIGAND PHARMACEUTICALS INC | LGND | Aryeh Jason Director | 2,893 | $0 | 131,041 (Direct) | View |
| 2024-03-05 Exercise | 2024-03-06 5:28 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Aryeh Jason Director | 2,893 | $39.35 | 131,041 (Direct) | View |